Method of preparing a high-purity, virus safe, biologically active transferrin preparation |
| We claim: 1. A method of preparing a high-purity, virus-safe biologically active, transferrin ... |
|
Hydrolyzable resin composition and an antifouling coating composition containing the same |
| What is claimed is: 1. A method of preventing marine fouling which comprises applying to a surface ... |
|
Treatment for herpes virus |
| OF THE INVENTION According to the invention, I provide a composition for and method of use of such ... |
|
Microbicidal meta oxy- and thio-substituted phenylanilines |
| What is claimed is: 1. A compound of the formula I, including salts and metal complexes thereof ##ST... |
|
Substituted acyl derivatives of amino acids |
| OF THE INVENTION The invention in its broad aspects includes substituted acyl derivatives of amino ... |
|
Escherichia coliO-polysaccharide-protein conjugate vaccine |
| OF THE INVENTION The present invention relates to E. coli-protein conjugates for use in vaccines ... |
|
Milk production |
| What is claimed is: 1. The method of improving rumen acetate/propionate ratios and milk production ... |
|
Heterocyclic compounds, processes for their preparation and their use |
| We claim: 1. A compound of general formula (I): ##STR14## in which the amide function is in the 2 ... |
|
Virus insecticide compositions |
| What is claimed is: 1. A particulate insecticidal composition comprising a free-flowing particle ... |
|
|
Process for preparing narasin
| Details |
Inventors: Kastner, Ralph E.; Hamil, Robert L.;
Assignee: Eli Lilly and Company (Indianapolis, IN)
Primary Examiner: Shapiro; Lionel M.
Assistant Examiner:
Attorney, Agent or Firm: Morrison; Dwight E., Whale; Arthur R.
The new microorganism Streptomyces granuloruber, NRRL 12389 and the fermentation process for preparing narasin by submerged aerobic fermentation of this organism. |
|
DETAILED DESCRIPTION The new microorganism of this invention is a biologically pure culture derived from a soil sample collected near the Surinam River, Surinam, South America. The culture was given the number A-39912 for identification purposes. Culture A-39912 is classified as Streptomyces granuloruber, based upon a simultaneous culturing of Streptomyces rubra; Streptomyces griseoruber; and Streptomyces griseoaurantiacus, using the methods and media recommended by Shirling and Gottlieb ["Methods of Characterization of Streptomyces species," Int. Bull. of Systematic Bacteriol. 16, 313-340 (1966)], along with certain supplementary tests. Culture A-39912 was also compared with the description of Streptomyces longispororuber reported by Gerber, J. Antibiot. 28, 194-199 (1975). Culture A-39912 differs from Streptomyces rubra by producing granules, that is, crystals of undecylprodiginine, a purplish-red dye, by producing a purplish-red to black vegetative mycelium, and by reducing nitrate. Culture A-39912 produces a red and gray aerial mycelium in contrast to the gray aerial mycelium of Streptomyces griseoruber. The purplish-red to black vegetative mycelium produced by culture A-39912 also differs from the yellow brown to reddish orange vegetative mycelium of Streptomyces griseoruber. Streptomyces griseoaurantiacus does not produce the distinctive purplish-red to black vegetative mycelium, as does culture A-39912. Neither Streptomyces griseoruber nor Streptomyces griseoaurantiacus produces the purplish-red crystals of undecylprodiginine as does A-39912. Thus, comparison of culture A-39912 with the above-named cultures shows significant differences. Our culture is considered to be a new species and is described as Streptomyces granuloruber. CHARACTERIZATION OF NARASIN-PRODUCING STRAIN Morphology Produces spiralled sporophores. The spores are smooth as determined by electron microscopy and are oval to slightly cylindrical in shape. The spores measure an average of 1. 3 . mu. m. times. 2. 015 . mu. m with a range of 1
|
| Related patents |
|
|
Reversible optical waveguide vapor sensor
Accordingly, it is an object of the invention to detect small amounts of a chemical in air and in other gases. Another object is to provide a device for such purpose ...
|
|
|
Biotinidase-resistant biotinylated compound and methods of use thereof
This invention relates to biotinidase-resistant biotinylated compounds containing a chemical fragment having the structure: ##STR2## wherein R.sub.1 and R.sub.3 are ...
|
|
|
Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
This invention provides a facile, efficient and reproducible method for recovering biologically active Shiga-like toxins from a sample using an affinity ligand ...
|
|
|
Assays for shiga toxin and shiga-like toxins
OF THE INVENTION The present invention relates to a substantially pure antigenic or peptide protein related to Shiga toxin (ST) or Shiga-like toxins I or II (SLT-II, SLT...
|
|
|
Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
OF THE INVENTION Histologic examination of colonic tissue has revealed no evidence of attachment of E. coli O157:H7 to bovine colonic tissue. The rumen appears to be ...
|
|
|
Feline leukemia virus vaccines
OF THE INVENTION Any immunogenic FeLV protein may be expressed in baculovirus following the methods and techniques described here. For instance, the location and ...
|
|
|
Resolution of D,L-dehydroproline
I claim: 1. A method for the preparation of L-3,4-dehydroproline comprising in combination the steps of: A. treating N-protected D,L-3,4-dehydroproline with R(+)-alpha-...
|
|
|
Quaternary salts as hypoglycemic agents
OF THE INVENTION The hypoglycemic agents of the present invention are synthesized by the reaction of a suitable halide with the appropriate heterocyclic ring system, ...
|
|
|
7-[.alpha.-(2-Aminomethyl-1-cyclohexenyl)-acetamido]-3-heterocyclic thiomethyl-3-cephem-4-carboxylic acids
We claim: 1. An acid having the formula ##SPC42## wherein R is ##SPC43## ##SPC44## or ##EQU1## or a nontoxic, pharmaceutically acceptable salt thereof. 2. The acid of ...
|
|
|
Pasteurized therapeutically active protein compositions
What is claimed is: 1. A method of pasteurizing a composition comprising a thermally sensitive, therapeutically active protein selected from the group consisiting of ...
|
|
|